Skip to main content

Closed

PLX: Protalix BioTherapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

54thpctl

Volume

1.67×avg

Market Cap

190.95MUSD

P/E Ratio

12.3TTM

Div Yield

-ann

Protalix BioTherapeutics, Inc.

PLXNew York Stock Exchange Arca·USD·Closed

Protalix BioTherapeutics, Inc.

PLXNew York Stock Exchange Arca·USD·Closed

$2.37

+4.41%

$2.37

+$0.10 (4.41%)

52W Range

54thpctl

Volume

1.67×avg

Mkt Cap

190.95MUSD

P/E

12.3TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings